+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization

RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization

Cancer Research 72(20): 5165-5173

RalBP1/RLIP76 is a widely expressed multifunctional protein that binds the Ral and R-Ras small GTPases. In the mouse, RLIP76 is nonessential but its depletion or blockade promotes tumorigenesis and heightens the sensitivity of normal and tumor cells to radiation and cytotoxic drugs. However, its pathobiologic functions, which support tumorigenesis, are not well understood. Here, we show that RLIP76 is required for angiogenesis and for efficient neovascularization of primary solid tumors. Tumor growth from implanted melanoma or carcinoma cells was blunted in RLIP76(-/-) mice. An X-ray microcomputed tomography-based method to model tumor vascular structures revealed defects in both the extent and form of tumor angiogenesis in RLIP76(-/-) mice. Specifically, tumor vascular volumes were diminished and vessels were fewer in number, shorter, and narrower in RLIP76(-/-) mice than in wild-type mice. Moreover, we found that angiogenesis was blunted in mutant mice in the absence of tumor cells, with endothelial cells isolated from these animals exhibiting defects in migration, proliferation, and cord formation in vitro. Taken together, our results establish that RLIP76 is required for efficient endothelial cell function and angiogenesis in solid tumors.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333059

Download citation: RISBibTeXText

PMID: 22902412

DOI: 10.1158/0008-5472.CAN-12-0468

Related references

Down-regulation of RACK1 suppresses tumor growth by inhibiting tumor cell proliferation and tumor-associated angiogenesis. 2011

Downregulation of receptor for activated C-kinase 1 (RACK1) suppresses tumor growth by inhibiting tumor cell proliferation and tumor-associated angiogenesis. Cancer Science 102(11): 2007-2013, 2011

Zinc depletion suppresses tumor growth in mice. Biological Trace Element Research 59(1-3): 23-29, 1997

Inhibiting colony stimulating factor -1 suppresses tumor growth in mice. FASEB Journal 16(5): A1205, March 22, 2002

Inhibiting delta-6 desaturase activity suppresses tumor growth in mice. Plos One 7(10): E47567-E47567, 2013

Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment. Oncotarget 6(16): 14428-14439, 2016

Experimental Studies Of Growth-Promoting And Growth-Inhibiting Substances Of Malignant Tumor Ii. Mitosis Promoting And Inhibiting Effects Of Extracts From Subcutaneous Ehrlich Ascites Tumor And Visceral Organs In Mice. Hiroshima Journal of Medical Sciences 13: 65-72, 1964

Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. Bmc Cancer 13(): 421-421, 2014

Inhibiting aurora kinases reduces tumor growth and suppresses tumor recurrence after chemotherapy in patient-derived triple-negative breast cancer xenografts. Molecular Cancer Therapeutics 11(12): 2693-2703, 2013

CAPE suppresses VEGFR-2 activation, and tumor neovascularization and growth. Journal of Molecular Medicine 91(2): 271-282, 2013

Human prostate tumor angiogenesis in nude mice: Metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells. Anatomical Record 249(1): 63-73, 1997

Tumor-specific expression of the RGD-(Sa(B3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice. FASEB journal t 20(11): 1904-1906, 2006

TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis. Cancer Immunology, ImmunoTherapy 62(4): 653-663, 2013